Back to top
more

U.S. Physical Therapy (USPH)

(Delayed Data from NYSE)

$100.61 USD

100.61
30,485

+0.23 (0.23%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $100.55 -0.06 (-0.06%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (151 out of 252)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for USPH

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for US Physical Therapy, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 153 32 29 33 24
Receivables 70 69 62 51 56
Notes Receivable 0 0 0 0 0
Inventories 0 0 0 0 0
Other Current Assets 11 11 4 4 6
Total Current Assets 233 111 95 88 85
Net Property & Equipment 26 25 23 22 22
Investments & Advances 12 12 12 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 619 603 521 402 370
Deposits & Other Assets 3 4 2 2 2
Total Assets 997 858 749 594 561
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 8 8 1 5 1
Accounts Payable 4 7 6 1 2
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 55 37 46 60 31
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 102 85 83 93 61
Mortgages 0 0 0 0 0
Deferred Taxes/Income 25 21 14 8 10
Convertible Debt 0 0 0 0 0
Long-Term Debt 139 176 118 17 50
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 2 13 7 5 0
Minority Interest (Liabilities) 175 168 155 132 138
Total Liabilities 520 541 452 317 319
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 281 110 103 96 87
Retained Earnings 224 233 224 212 184
Other Equity 4 5 2 1 1
Treasury Stock 32 32 32 32 32
Total Shareholder's Equity 477 317 297 278 242
Total Liabilities & Shareholder's Equity 997 858 749 594 561
Total Common Equity 477 317 297 278 242
Shares Outstanding 14.90 13.00 12.90 12.80 12.70
Book Value Per Share 32.04 24.39 23.04 21.69 19.03

Fiscal Year End for US Physical Therapy, Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 153 148 161 33
Receivables NA 70 71 71 74
Notes Receivable NA 0 0 0 0
Inventories NA 0 0 0 0
Other Current Assets NA 11 9 10 11
Total Current Assets NA 233 229 242 118
Net Property & Equipment NA 26 26 25 25
Investments & Advances NA 12 12 12 12
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 619 635 614 610
Deposits & Other Assets NA 3 6 5 3
Total Assets NA 997 1,010 1,000 868
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 8 8 8 8
Accounts Payable NA 4 5 4 4
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 55 36 43 45
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities NA 102 82 86 91
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 25 26 23 22
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 139 142 143 183
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 15 13 14
Minority Interest (Liabilities) NA 175 175 166 164
Total Liabilities NA 520 517 510 549
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 281 279 277 112
Retained Earnings NA 224 239 238 235
Other Equity NA 4 7 6 4
Treasury Stock NA 32 32 32 32
Total Shareholder's Equity NA 477 494 490 319
Total Liabilities & Shareholder's Equity NA 997 1,010 1,000 868
Total Common Equity 0 477 494 490 319
Shares Outstanding 15.00 14.90 14.90 13.00 13.00
Book Value Per Share 0.00 32.04 33.12 37.69 24.58